FDA Resignation: Vinay Prasad Steps Down Amidst Controversies
Published on: July 30, 2025, 2:16 p.m. | Source: Devdiscourse
Vinay Prasad, the FDA's chief medical and science officer, has resigned amid controversy surrounding a gene therapy drug for Duchenne muscular dystrophy. Prasad, who did not want to be a distraction, is returning to California. His departure follows several contentious FDA decisions on Sarepta Therapeutics' Elevidys.
